Home
Conditions
Colonic Diseases

Clinical trial condition

Colonic Diseases

Explore clinical trials studying Colonic Diseases. Study availability and eligibility vary by location and protocol.

7,486 public trials 1,473 recruiting studies

Refine in advanced search Browse all conditions

Colonic Diseases trial results

Active, Not Recruiting

Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC)

NCT03907631

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations: Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust Hull, United Kingdom

View Trial Details

Active, Not Recruiting

Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer

NCT05171660

Conditions: Colonic Diseases, Colorectal Cancer Stage IV, Colorectal Neoplasms, +9 more
Locations: Xuefeng Fang Hangzhou, Zhejiang, China

View Trial Details

Active, Not Recruiting

Early Commencement of Adjuvant Chemotherapy for Colon Cancer

NCT01460589

Conditions: Colon Cancer, Colonic Diseases, Colonic Neoplasms, +9 more
Locations: Kyungpook National University Medical center Daegu, South Korea

Jun Seok Park Daegu, South Korea

View Trial Details

Active, Not Recruiting

Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer

NCT03426904

Conditions: Colon Cancer, Colonic Diseases, Colonic Neoplasms, +9 more
Locations: Chonnam National University Hwasun Hospital Hwasun, Chonnam, South Korea

Kyungpook National University Chilgok Hospital Daegu, South Korea

Asan Medical Center Seoul, South Korea

The Catholic Univ. of Korea St. Vincent's Hospital Suwon, South Korea

View Trial Details

Active, Not Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations: University of California, Irvine Medical Center Irvine, California, United States

Cedars Sinai Medical Center Los Angeles, California, United States

University of California, San Diego San Diego, California, United States

University of California, San Francisco San Francisco, California, United States

View all 14 locations

View Trial Details

Active, Not Recruiting

The Diverticulitis Study

NCT06023004

Conditions: Acute Diverticulitis, Colonic Diseases, Colonic Diverticulitis, +16 more
Locations: Herlev Hospital Herlev, Capital Region of Denmark, Denmark

Regional Hospital Horsens Horsens, Central Jutland, Denmark

Regional Hospital Randers Randers, Central Jutland, Denmark

Regional Hospital Viborg Viborg, Central Jutland, Denmark

View Trial Details

Active, Not Recruiting

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

NCT01815359

Conditions: Appendiceal Neoplasms, Appendix Cancer, Cecal Diseases, +13 more
Locations: University of Miami Miami, Florida, United States

Washington University School of Medicine St Louis, Missouri, United States

Memorial Sloan Kettering Basking Ridge (Consent and Follow up) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Consent and Follow up) Middletown, New Jersey, United States

View Trial Details

Active, Not Recruiting

Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes

NCT02371135

Conditions: Colonic Diseases, Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, +16 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)

NCT06206265

Conditions: Colonic Diseases, Colonic Diseases, Functional, Digestive System Diseases, +3 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Botensilimab and Balstilimab Optimization in Colorectal Cancer

NCT06268015

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
Locations: Duke University Durham, North Carolina, United States

View Trial Details

Colonic Diseases

Colonic Diseases trial results

Related conditions